ALLR vs CRL · P/E 0.0, rev $25.0K vs rev $2.00B
Allarity Therapeutics Inc (ALLR) versus Charles River Laboratories (CRL) — a side-by-side from cached financials, not a winner call.
Allarity Therapeutics Inc (ALLR) is a biotechnology company listed on US.
Charles River Laboratories (CRL) is a diagnostics & research company listed on US.
Latest reported ALLR revenue for 2026-06-30 was $25.0K. Net income was -$6.2M. Revenue was up 0.0% from 2026-03-31 to 2026-06-30. ALLR currently screens at market cap $15.1M and trailing P/E 0.0.
Latest reported CRL revenue for 2026-06-27 was $2.00B. Net income was -$16.3M. CRL currently screens at market cap $7.78B.
ALLR currently screens at market cap $15.1M and trailing P/E 0.0. CRL currently screens at market cap $7.78B.
Not investment advice. Open the ALLR and CRL stock pages for the full models.
Not investment advice.